Bayer sued for allegedly monopolizing US market for GMO corn seeds
The lawsuit says Bayer blocked generic competition and kept prices high after NK603 patent protections expired, hurting farmers and independent seed companies.
9 Articles
9 Articles
There are already thousands of lawsuits against Bayer in the USA. A new one is added: A company from Iowa accuses the Group of monopolizing the market for maissage. Bayer rejects the allegations.
A US seed company accuses Bayer of monopolizing the market for genetically modified maize and artificially increasing prices. The Group rejects the allegations.
Bayer is accused of monopolizing the U.S. genetically modified corn seed market. On May 27, Bayer faced a proposed class-action lawsuit filed in the U.S. District Court for the Eastern District of Missouri, alleging anti-competitive behavior in the genetically modified corn seed market. The lawsuit claims that Bayer monopolized the market in 2022.
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium






